iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
IBIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.80%61.580.0%$914.89m
NVAXNovavax, Inc. -5.99%98.30102.0%$790.47m
AMGNAmgen, Inc. -0.62%251.591.3%$725.25m
REGNRegeneron Pharmaceuticals, Inc. -0.08%640.342.5%$677.64m
GILDGilead Sciences, Inc. -1.06%75.611.0%$627.17m
BIIBBiogen, Inc. 4.41%280.191.6%$622.60m
VRTXVertex Pharmaceuticals, Inc. -1.05%295.921.9%$509.00m
ILMNIllumina, Inc. -0.61%369.873.5%$300.06m
ALXNAlexion Pharmaceuticals, Inc. -3.97%108.002.0%$219.47m
BMRNBioMarin Pharmaceutical, Inc. 0.59%128.734.3%$214.30m
SGENSeattle Genetics, Inc. -0.35%175.536.1%$200.21m
SRNESorrento Therapeutics, Inc. -1.22%7.291.8%$180.15m
IMMUImmunomedics, Inc. 0.95%41.5511.0%$179.47m
SRPTSarepta Therapeutics, Inc. 3.82%170.1513.9%$164.96m
ALNYAlnylam Pharmaceuticals, Inc. 0.26%160.428.5%$164.06m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.